Antonio Pineda-Lucena
Antonio Pineda-Lucena
Principal Investigator
Verifierad e-postadress på
Citeras av
Citeras av
Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A
E Bochkareva, L Kaustov, A Ayed, GS Yi, Y Lu, A Pineda-Lucena, ...
Proceedings of the National Academy of Sciences 102 (43), 15412-15417, 2005
An NMR approach to structural proteomics
A Yee, X Chang, A Pineda-Lucena, B Wu, A Semesi, B Le, T Ramelot, ...
Proceedings of the National Academy of Sciences 99 (4), 1825-1830, 2002
NMR Solution Structure of the Isolated N-Terminal Fragment of Protein-G B1 Domain. Evidence of Trifluoroethanol Induced Native-Like. beta.-Hairpin Formation
FJ Blanco, MA Jimenez, A Pineda, M Rico, J Santoro, JL Nieto
Biochemistry 33 (19), 6004-6014, 1994
Serum metabolome analysis by 1 H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups
DA MacIntyre, B Jimenez, EJ Lewintre, CR Martín, H Schäfer, ...
Leukemia 24 (4), 788-797, 2010
A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants
A Rodríguez, J Roy, S Martínez-Martínez, MD López-Maderuelo, ...
Molecular cell 33 (5), 616-626, 2009
Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes
A Herrero, A Pinto, P Colón-Bolea, B Casar, M Jones, L Agudo-Ibáñez, ...
Cancer cell 28 (2), 170-182, 2015
1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor
RM Lozano, A Pineda-Lucena, C Gonzalez, M Angeles Jimenez, ...
Biochemistry 39 (17), 4982-4993, 2000
A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants
A Pineda-Lucena, CSW Ho, DYL Mao, Y Sheng, RC Laister, ...
Journal of molecular biology 351 (1), 182-194, 2005
Polymer conjugates as therapeutics: future trends, challenges and opportunities
MJ Vicent, L Dieudonne, RJ Carbajo, A Pineda-Lucena
Expert opinion on drug delivery 5 (5), 593-614, 2008
Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog
A Pineda-Lucena, MÁ Jiménez, RM Lozano, JL Nieto, J Santoro, M Rico, ...
Journal of molecular biology 264 (1), 162-178, 1996
Serum Metabolic Signature of Minimal Hepatic Encephalopathy by 1H-Nuclear Magnetic Resonance
B Jiménez, C Montoliu, DA MacIntyre, MA Serra, A Wassel, M Jover, ...
Journal of proteome research 9 (10), 5180-5187, 2010
Deciphering biosynthesis of the RNA polymerase inhibitor streptolydigin and generation of glycosylated derivatives
C Olano, C Gómez, M Pérez, M Palomino, A Pineda-Lucena, RJ Carbajo, ...
Chemistry & biology 16 (10), 1031-1044, 2009
Structure and function of the PWI motif: a novel nucleic acid-binding domain that facilitates pre-mRNA processing
BR Szymczyna, J Bowman, S McCracken, A Pineda-Lucena, Y Lu, B Cox, ...
Genes & development 17 (4), 461-475, 2003
Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A
N Canela, M Orzáez, R Fucho, F Mateo, R Gutierrez, A Pineda-Lucena, ...
Journal of Biological Chemistry 281 (47), 35942-35953, 2006
1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfate
A Pineda-Lucena, MA Jiménez, JL Nieto, J Santoro, M Rico, ...
Journal of molecular biology 242 (1), 81-98, 1994
Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation
M Sanz-Cortés, RJ Carbajo, F Crispi, F Figueras, A Pineda-Lucena, ...
PloS one 8 (12), e80121, 2013
Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles
C Sánchez, AP Salas, AF Braña, M Palomino, A Pineda-Lucena, ...
Chemical communications, 4118-4120, 2009
Selective pressures at a codon-level predict deleterious mutations in human disease genes
L Arbiza, S Duchi, D Montaner, J Burguet, D Pantoja-Uceda, ...
Journal of molecular biology 358 (5), 1390-1404, 2006
QSAR-based permeability model for drug-like compounds
R Gozalbes, M Jacewicz, R Annand, K Tsaioun, A Pineda-Lucena
Bioorganic & medicinal chemistry 19 (8), 2615-2624, 2011
Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission
L Puchades-Carrasco, R Lecumberri, J Martínez-López, JJ Lahuerta, ...
Clinical cancer research 19 (17), 4770-4779, 2013
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20